Papers
3
Total Citations
83
H-Index
3
About
Yecheng Lin is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, particularly through robotic and laparoscopic approaches. His major contributions center on optimizing lymph node dissection using innovative tracer technologies. Lin's landmark 2021 study (35 citations) pioneered the comparative analysis of carbon nanoparticle suspension injection (CNSI) and indocyanine green (ICG) for lymph node mapping during robotic distal gastrectomy, demonstrating their safety and efficacy. He further validated CNSI's diagnostic value in a 2022 study (28 citations), establishing it as a reliable tool for visualizing lymphatic drainage in gastric cancer. In 2023, Lin expanded his work to Enhanced Recovery After Surgery (ERAS) protocols, comparing total robotic versus 3D laparoscopic distal gastrectomy (20 citations), showing that robotic surgery can be safely integrated into ERAS pathways. His research has significantly impacted surgical practice by providing evidence for personalized lymphadenectomy strategies and improving perioperative outcomes. With over 80 cumulative citations, Lin's work bridges surgical innovation and patient-centered care, making him a respected voice in gastrointestinal oncology and robotic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3